An increase of both MuRF1 and atrogin-1 expression in diabetic CASMCs may synergistically accelerate BK-β1 protein degradation and exacerbate BK channel-mediated coronary arterial dysfunction in diabetes. The gene discussed is TRIM63; the disease is diabetes mellitus.